ClinicalTrials.govpublic full text
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
psp - progressive supranuclear palsy, psp, placebo-controlled, double-blind, regimen specific appendix, lm11a-31, tau protein, oral treatment, disease modifying, p75 neurotrophin receptor, synaptic resilience, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 981361
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.